Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

871.42 +13.95 (+1.63%)
Streaming Delayed Price Updated: 2:44 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group – English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his... 
Via FinancialNewsMedia
Eli Lilly Dividend: Does Eli Lilly Pay Dividends?
Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all... 
Via MarketBeat
Watch for Continued Gains in Shares of Eli Lilly and Company (LLY)
Via Investor Brand Network
Watch for Continued Gains in Shares of Eli Lilly and Company (LLY)
Via Investor Brand Network
Watch for Continued Gains in Shares of Eli Lilly and Company (LLY)
Via Investor Brand Network
Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development 
Via Spotlight Growth
Exposures Product Safety
Amgen Shares Leap Higher On Upbeat Outlook For Obesity Treatment
Shares of Amgen soared 5.72% Tuesday and added to those gains Wednesday. The gap-up followed a Morgan Stanley upgrade and increase to the price target. 
Via MarketBeat
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Here is a look at three names that buy-and-hold investors may want to consider as the race to find a cure for Alzheimer's disease accelerates 
Via MarketBeat
Exposures Product Safety
Highest Gross Margin in the Drug Manufacturers Industry Detected in Shares of Bristol-Myers Squibb Company (BMY, LLY, ZOM, BHC, ABBV)
Via Investor Brand Network
Watch for Continued Gains in Shares of Eli Lilly and Company (LLY)
Via Investor Brand Network
Is Sanofi A Buy, Despite Recent Stumbles?
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via TheNewswire.com
Exposures Product Safety
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Amphetamine Drug Market 2022: Industry Analysis, Size, Global Trends, Share, Growth, Opportunity and Forecast to 2028
Amphetamine Drug Market SWOT Analysis Including Key Players Pfizer, Novartis, Eli Lilly, GSK, Hisamitsu Pharmaceutical, Purdue Pharma 
Via SBWire
Global Liposarcoma Treatment Market 2022 Business Strategies and Overview Report 2031 Taro Pharmaceuticals, Sandoz, Pfizer, Eli Lilly, Sanofi SA, Novartis AG
The intelligent report on the global Liposarcoma Treatment market provides deep analysis of the Liposarcoma Treatment industry segments including product type, application, special geographies and... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Medical Stocks Bucking the Bear Trend on Positive News (WHSI, IVC, SPOM, BIMI, RVVTF)
Via AB Newswire
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi Sankyo.
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi... 
Via iCrowdNewswire
SWOT Analysis on Diabetes Devices Sales Market Revenue 2022-2029 : Medtronic, Sanofi, Novo Nordisk, Medtronic
Global Diabetes Devices Market Research 2022-2031 published by Calibre Research studies the current situation, Diabetes Devices market size, share, trends, regional growth and the latest technologies... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Breakthroughs In Treating Killer Diseases Could Lengthen Life
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal... 
Via FinancialNewsMedia
Topics Death
Exposures Death
Dr. Jeffrey Kasher Joins Pro-Ficiency Board of Directors
Pro-ficiency, a pioneer in the field of simulation-based training in clinical trials, has opened up a select number of seats on the Company's Board of Directors. Dr. Jeffrey Kasher, a renowned... 
Via Newswire.com
Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood... 
Via FinancialNewsMedia
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach... 
Via iCrowdNewswire
Veterinary Antibiotics Market Research Insight 2022| Key Players are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Ve
Via iCrowdNewswire
Exposures COVID-19
Heart Failure Treatment Offers Hope to Diabetics
Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart... 
Via FinancialNewsMedia
Smart Insulin Pen Market Size 2022 SWOT Analysis by Key Players – Companion Medical, Digital Medics Ptd, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co.
Smart Insulin Pens s valued approximately USD 89.53 million in 2020 and is anticipated to grow with a healthy growth rate of more than 10.77% over the forecast period 2022-2028. 
Via SBWire
Industry Expert Steve Dietze Joins Trace Genomics as VP of Strategic Operations
Trace Genomics has announced Steve Dietze as its new vice president of strategic operations. Dietze's extensive experience in operations will further solidify Traces' excellence in commercial... 
Via Newswire.com
Topics Retirement
Exposures Pension
U.S. Hispanic Business Council Announces Cristina Antelo as a Member of the Board
The United States Hispanic Business Council (USHBC) announced today the appointment of Cristina Antelo, founder of Ferox Strategies, to its Board of Directors as Legislative Co-Chair. 
Via Newswire.com
GLP-1 Receptor Agonist Market | Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2020 – 2027 | Grand View Research, Inc.
Via AB Newswire
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.